Published in J Physiol on January 20, 2005
The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease. Nat Rev Immunol (2011) 2.77
Lack of exercise is a major cause of chronic diseases. Compr Physiol (2012) 2.19
Dynamic regulation of circulating microRNA during acute exhaustive exercise and sustained aerobic exercise training. J Physiol (2011) 1.71
Acute physical exercise reverses S-nitrosation of the insulin receptor, insulin receptor substrate 1 and protein kinase B/Akt in diet-induced obese Wistar rats. J Physiol (2007) 1.38
LL37 and cationic peptides enhance TLR3 signaling by viral double-stranded RNAs. PLoS One (2011) 1.08
Single-stranded oligonucleotides can inhibit cytokine production induced by human toll-like receptor 3. Mol Cell Biol (2008) 0.97
Functional crosstalk of PGC-1 coactivators and inflammation in skeletal muscle pathophysiology. Semin Immunopathol (2013) 0.93
The influence of prolonged cycling on monocyte Toll-like receptor 2 and 4 expression in healthy men. Eur J Appl Physiol (2010) 0.88
Effect of selective serotonin reuptake inhibitors and immunomodulator on cytokines levels: an alternative therapy for patients with major depressive disorder. Clin Dev Immunol (2013) 0.85
Effects of exercise on weight loss and monocytes in obese mice. Comp Med (2012) 0.84
Cross-training in birds: cold and exercise training produce similar changes in maximal metabolic output, muscle masses and myostatin expression in house sparrows (Passer domesticus). J Exp Biol (2015) 0.84
Modulation of dendritic cells and toll-like receptors by marathon running. Eur J Appl Physiol (2011) 0.82
Influence of Acute and Chronic Exercise on Glucose Uptake. J Diabetes Res (2016) 0.81
Role of exercise training on autonomic changes and inflammatory profile induced by myocardial infarction. Mediators Inflamm (2014) 0.80
The impact of acute strenuous exercise on TLR2, TLR4 and HLA.DR expression on human blood monocytes induced by autologous serum. Eur J Appl Physiol (2010) 0.79
Exhaustive exercise reduces TNF-α and IFN-α production in response to R-848 via toll-like receptor 7 in mice. Eur J Appl Physiol (2010) 0.78
The role of the hypothalamic-pituitary-adrenal axis in modulating seasonal changes in immunity. Physiol Genomics (2016) 0.76
Impact of Exercise on Innate Immunity in Multiple Sclerosis Progression and Symptomatology. Front Physiol (2016) 0.75
Acute high-intensity interval exercise reduces human monocyte Toll-like receptor 2 expression in type 2 diabetes. Am J Physiol Regul Integr Comp Physiol (2017) 0.75
Exercise-Induced Release of Pharmacologically Active Substances and Their Relevance for Therapy of Hepatic Injury. Front Pharmacol (2016) 0.75
Rapid Exercise-Induced Mobilization of Dendritic Cells Is Potentially Mediated by a Flt3L- and MMP-9-Dependent Process in Multiple Sclerosis. Mediators Inflamm (2015) 0.75
Innate immune recognition. Annu Rev Immunol (2001) 26.65
A Toll-like receptor recognizes bacterial DNA. Nature (2000) 26.34
Toll-like receptors. Annu Rev Immunol (2001) 26.06
Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature (2001) 25.15
A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature (1997) 23.92
The dorsoventral regulatory gene cassette spätzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell (1996) 17.42
Toll-like receptors and innate immunity. Nat Rev Immunol (2001) 16.50
The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature (2001) 14.24
Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science (2003) 14.04
Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science (1999) 7.75
Inferences, questions and possibilities in Toll-like receptor signalling. Nature (2004) 7.57
Toll-like receptors control activation of adaptive immune responses. Nat Immunol (2001) 7.54
Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J Immunol (2000) 6.61
Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4. Nature (2002) 4.81
Induction of direct antimicrobial activity through mammalian toll-like receptors. Science (2001) 4.46
The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF. J Immunol (2002) 3.75
Exercise and the immune system: regulation, integration, and adaptation. Physiol Rev (2000) 3.42
Cutting edge: MyD88 is required for resistance to Toxoplasma gondii infection and regulates parasite-induced IL-12 production by dendritic cells. J Immunol (2002) 3.12
Cutting edge: impaired Toll-like receptor expression and function in aging. J Immunol (2002) 3.04
Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1- and TLR2-deficient mice. Nat Med (2002) 2.77
Muscle-derived interleukin-6: mechanisms for activation and possible biological roles. FASEB J (2002) 2.66
Critical roles of myeloid differentiation factor 88-dependent proinflammatory cytokine release in early phase clearance of Listeria monocytogenes in mice. J Immunol (2002) 2.61
Inflammatory response after open heart surgery: release of heat-shock protein 70 and signaling through toll-like receptor-4. Circulation (2002) 2.44
Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J (2002) 2.26
Activation and regulation of Toll-like receptors 2 and 1 in human leprosy. Nat Med (2003) 2.08
IFNs activate toll-like receptor gene expression in viral infections. Genes Immun (2001) 1.90
Heterogeneity of human blood monocytes: the CD14+ CD16+ subpopulation. Immunol Today (1996) 1.82
Expression and regulation of Toll-like receptor 2 in rheumatoid arthritis synovium. Am J Pathol (2003) 1.79
Vitamin C supplementation reduces the incidence of postrace symptoms of upper-respiratory-tract infection in ultramarathon runners. Am J Clin Nutr (1993) 1.69
Glucocorticoids synergistically enhance nontypeable Haemophilus influenzae-induced Toll-like receptor 2 expression via a negative cross-talk with p38 MAP kinase. J Biol Chem (2002) 1.67
Infectious episodes in runners before and after the Los Angeles Marathon. J Sports Med Phys Fitness (1990) 1.61
Inhibition of p38 MAPK by glucocorticoids via induction of MAPK phosphatase-1 enhances nontypeable Haemophilus influenzae-induced expression of toll-like receptor 2. J Biol Chem (2002) 1.44
Diurnal and acute stress-induced changes in distribution of peripheral blood leukocyte subpopulations. Brain Behav Immun (1994) 1.39
Ultramarathon running and upper respiratory tract infections. An epidemiological survey. S Afr Med J (1983) 1.38
Exercise and the immune system. Immunol Today (1988) 1.33
Selective mobilization of CD14(+)CD16(+) monocytes by exercise. Am J Physiol Cell Physiol (2000) 1.24
Diurnal rhythmicity of human cytokine production: a dynamic disequilibrium in T helper cell type 1/T helper cell type 2 balance? J Immunol (1997) 1.23
Role of NFkappaB in antigen presentation and development of regulatory T cells elucidated by treatment of dendritic cells with the proteasome inhibitor PSI. Eur J Immunol (2001) 1.13
Endotoxaemia modulates Toll-like receptors on leucocytes in humans. Br J Haematol (2003) 1.00
Heat stress increases muscle glycogen use but reduces the oxidation of ingested carbohydrates during exercise. J Appl Physiol (1985) (2002) 0.89
Transcriptional and post-transcriptional mechanisms of glucocorticoid antiproliferative effects. Hematol Oncol (2002) 0.88
Human toll-like receptors 2 and 4 are targets for deactivation of mononuclear phagocytes by interleukin-4. Immunol Lett (2000) 0.82
Chronobiological aspects of the neuroendocrine-immune network. Regulation of human natural killer (NK) cell activity as a model. Chronobiologia (1993) 0.77
High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. N Engl J Med (2003) 8.93
First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial. Lancet (2010) 5.04
Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet (2006) 4.23
Minimal residual disease assessed by multiparameter flow cytometry in multiple myeloma: impact on outcome in the Medical Research Council Myeloma IX Study. J Clin Oncol (2013) 3.75
Position statement. Part one: Immune function and exercise. Exerc Immunol Rev (2011) 3.69
The value of resident presentations at scientific meetings. Laryngoscope (2013) 3.48
Serum test for assessment of patients with Bence Jones myeloma. Lancet (2003) 3.04
Dysregulated humoral immunity to nontyphoidal Salmonella in HIV-infected African adults. Science (2010) 2.91
The role of maintenance thalidomide therapy in multiple myeloma: MRC Myeloma IX results and meta-analysis. Blood (2011) 2.69
Heart rate monitoring: applications and limitations. Sports Med (2003) 2.58
IgM myeloma: a rare entity characterized by a CD20-CD56-CD117- immunophenotype and the t(11;14). Br J Haematol (2008) 2.54
Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T-cell subset. Immunology (2004) 2.51
The neglected role of antibody in protection against bacteremia caused by nontyphoidal strains of Salmonella in African children. J Clin Invest (2008) 2.35
Assessment of monoclonal gammopathies by nephelometric measurement of individual immunoglobulin kappa/lambda ratios. Clin Chem (2009) 1.99
Early mortality after diagnosis of multiple myeloma: analysis of patients entered onto the United kingdom Medical Research Council trials between 1980 and 2002--Medical Research Council Adult Leukaemia Working Party. J Clin Oncol (2005) 1.97
The effect of 2 weeks vitamin C supplementation on immunoendocrine responses to 2.5 h cycling exercise in man. Eur J Appl Physiol (2006) 1.96
Beetroot juice and exercise: pharmacodynamic and dose-response relationships. J Appl Physiol (1985) (2013) 1.87
Effective therapeutic use of rituximab in refractory Wegener's granulomatosis. Nephrol Dial Transplant (2005) 1.87
RIDDLE immunodeficiency syndrome is linked to defects in 53BP1-mediated DNA damage signaling. Proc Natl Acad Sci U S A (2007) 1.79
Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised controlled trial. Lancet Oncol (2011) 1.71
Importance of antibody and complement for oxidative burst and killing of invasive nontyphoidal Salmonella by blood cells in Africans. Proc Natl Acad Sci U S A (2010) 1.68
Determination of the exercise intensity that elicits maximal fat oxidation. Med Sci Sports Exerc (2002) 1.67
Monoclonal gammopathy of undetermined significance and risk of lymphoid and myeloid malignancies: 728 cases followed up to 30 years in Sweden. Blood (2013) 1.64
Acceleration versus heart rate for estimating energy expenditure and speed during locomotion in animals: tests with an easy model species, Homo sapiens. Zoology (Jena) (2008) 1.60
Caffeine improves physical and cognitive performance during exhaustive exercise. Med Sci Sports Exerc (2008) 1.58
Carbohydrates for training and competition. J Sports Sci (2011) 1.56
Prevention, diagnosis, and treatment of the overtraining syndrome: joint consensus statement of the European College of Sport Science and the American College of Sports Medicine. Med Sci Sports Exerc (2013) 1.49
Position statement. Part two: Maintaining immune health. Exerc Immunol Rev (2011) 1.49
Validity, reliability and sensitivity of measures of sporting performance. Sports Med (2008) 1.49
Markers to measure immunomodulation in human nutrition intervention studies. Br J Nutr (2005) 1.42
Integrated media presentation in multidisciplinary head and neck oncology meetings. Eur Arch Otorhinolaryngol (2008) 1.38
Green tea extract ingestion, fat oxidation, and glucose tolerance in healthy humans. Am J Clin Nutr (2008) 1.34
The effect of carbohydrate mouth rinse on 1-h cycle time trial performance. Med Sci Sports Exerc (2004) 1.33
How I treat monoclonal gammopathy of renal significance (MGRS). Blood (2013) 1.33
Cyclophosphamide, thalidomide, and dexamethasone (CTD) as initial therapy for patients with multiple myeloma unsuitable for autologous transplantation. Blood (2011) 1.32
Cyclophosphamide, thalidomide, and dexamethasone as induction therapy for newly diagnosed multiple myeloma patients destined for autologous stem-cell transplantation: MRC Myeloma IX randomized trial results. Haematologica (2011) 1.32
Determinants of fat oxidation during exercise in healthy men and women: a cross-sectional study. J Appl Physiol (1985) (2004) 1.32
Does overtraining exist? An analysis of overreaching and overtraining research. Sports Med (2004) 1.31
Flow cytometric disease monitoring in multiple myeloma: the relationship between normal and neoplastic plasma cells predicts outcome after transplantation. Blood (2002) 1.22
Endurance training and obesity: effect on substrate metabolism and insulin sensitivity. Med Sci Sports Exerc (2008) 1.22
Optimizing fat oxidation through exercise and diet. Nutrition (2004) 1.18
Branched-chain amino acid ingestion can ameliorate soreness from eccentric exercise. Med Sci Sports Exerc (2010) 1.16
Levels of autoantibodies, unlike antibodies to all extrinsic antigen groups, fall following B cell depletion with Rituximab. Eur J Immunol (2008) 1.14
Long-term follow-up of MRC Myeloma IX trial: Survival outcomes with bisphosphonate and thalidomide treatment. Clin Cancer Res (2013) 1.11
Effects of exercise intensity on salivary antimicrobial proteins and markers of stress in active men. J Sports Sci (2008) 1.10
The effect of glucose infusion on glucose kinetics during a 1-h time trial. Med Sci Sports Exerc (2004) 1.10
Salivary IgA as a risk factor for upper respiratory infections in elite professional athletes. Med Sci Sports Exerc (2008) 1.10
Validity and reliability of three commercially available breath-by-breath respiratory systems. Eur J Appl Physiol (2002) 1.08
Finger-prick blood samples can be used interchangeably with venous samples for CD4 cell counting indicating their potential for use in CD4 rapid tests. AIDS (2007) 1.08
The serotonin transporter (SLC6A4) is present in B-cell clones of diverse malignant origin: probing a potential anti-tumor target for psychotropics. FASEB J (2005) 1.07
Effects of acute exhaustive exercise and chronic exercise training on type 1 and type 2 T lymphocytes. Exerc Immunol Rev (2004) 1.07
Fat oxidation rates are higher during running compared with cycling over a wide range of intensities. Metabolism (2003) 1.06
Physical inactivity and obesity: links with insulin resistance and type 2 diabetes mellitus. Diabetes Metab Res Rev (2009) 1.06
Carbohydrate mouth rinsing in the fed state: lack of enhancement of time-trial performance. Int J Sport Nutr Exerc Metab (2009) 1.05
The effect of feeding frequency on insulin and ghrelin responses in human subjects. Br J Nutr (2008) 1.05
Acute and chronic effects of exercise on markers of mucosal immunity. Front Biosci (Landmark Ed) (2009) 1.04
Dendritic cell uptake of human apoptotic and necrotic neutrophils inhibits CD40, CD80, and CD86 expression and reduces allogeneic T cell responses: relevance to systemic vasculitis. Arthritis Rheum (2003) 1.03
Combined bezafibrate and medroxyprogesterone acetate: potential novel therapy for acute myeloid leukaemia. PLoS One (2009) 1.03
Immunological responses to overreaching in cyclists. Med Sci Sports Exerc (2003) 1.02
Hypoxia triggers major metabolic changes in AML cells without altering indomethacin-induced TCA cycle deregulation. ACS Chem Biol (2010) 1.01
Selective serotonin reuptake inhibitors directly signal for apoptosis in biopsy-like Burkitt lymphoma cells. Blood (2002) 1.00
Combined ingestion of protein and carbohydrate improves protein balance during ultra-endurance exercise. Am J Physiol Endocrinol Metab (2004) 0.99
The effect of single and repeated bouts of prolonged cycling and circadian variation on saliva flow rate, immunoglobulin A and alpha-amylase responses. J Sports Sci (2005) 0.98
The t(14;20) is a poor prognostic factor in myeloma but is associated with long-term stable disease in monoclonal gammopathies of undetermined significance. Haematologica (2010) 0.98
High rates of exogenous carbohydrate oxidation from a mixture of glucose and fructose ingested during prolonged cycling exercise. Br J Nutr (2005) 0.97
Time course of performance changes and fatigue markers during intensified training in trained cyclists. J Appl Physiol (1985) (2002) 0.97
Carbohydrate ingestion improves performance of a new reliable test of soccer performance. Int J Sport Nutr Exerc Metab (2009) 0.95
Carbohydrate supplementation improves moderate and high-intensity exercise in the heat. Pflugers Arch (2003) 0.94
Elevated plasma interleukin-6 levels in trained male triathletes following an acute period of intense interval training. Eur J Appl Physiol (2006) 0.94
Fatigue management in the preparation of Olympic athletes. J Sports Sci (2009) 0.94
Oxidation of combined ingestion of glucose and fructose during exercise. J Appl Physiol (1985) (2003) 0.94
A pilot study of fibreoptic endoscopic evaluation of swallowing in patients with cuffed tracheostomies in neurological intensive care. Neurocrit Care (2007) 0.94
Superior endurance performance with ingestion of multiple transportable carbohydrates. Med Sci Sports Exerc (2008) 0.94
Adaptive trials in the neoadjuvant setting: a model to safely tailor care while accelerating drug development. J Clin Oncol (2012) 0.93
Parental caregivers of children with developmental disabilities mount a poor antibody response to pneumococcal vaccination. Brain Behav Immun (2008) 0.93
Caffeine increases exogenous carbohydrate oxidation during exercise. J Appl Physiol (1985) (2005) 0.93
The metabolic and performance effects of caffeine compared to coffee during endurance exercise. PLoS One (2013) 0.93
Salivary antimicrobial peptides (LL-37 and alpha-defensins HNP1-3), antimicrobial and IgA responses to prolonged exercise. Eur J Appl Physiol (2009) 0.93
Rudimentary signs of immunosenescence in Cytomegalovirus-seropositive healthy young adults. Age (Dordr) (2013) 0.93
A contemporary review of balance dysfunction following vestibular schwannoma surgery. Laryngoscope (2009) 0.93
The value of resident presentations at scientific meetings. JAMA Otolaryngol Head Neck Surg (2013) 0.92
Acute exercise mobilises CD8+ T lymphocytes exhibiting an effector-memory phenotype. Brain Behav Immun (2009) 0.92
The inner ear and the neurologist. J Neurol Neurosurg Psychiatry (2007) 0.92
The value of resident presentations at scientific meetings. Otol Neurotol (2013) 0.91
Treatment of chronic lymphocytic leukemia requires targeting of the protective lymph node environment with novel therapeutic approaches. Leuk Lymphoma (2011) 0.91
Exogenous carbohydrate oxidation rates are elevated after combined ingestion of glucose and fructose during exercise in the heat. J Appl Physiol (1985) (2005) 0.91
Management of large and giant vestibular schwannomas. Skull Base (2011) 0.91
Nutritional intake and gastrointestinal problems during competitive endurance events. Med Sci Sports Exerc (2012) 0.91
Soluble syndecan-1 level at diagnosis is an independent prognostic factor in multiple myeloma and the extent of fall from diagnosis to plateau predicts for overall survival. Br J Haematol (2005) 0.90